IBIO, INC. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets
IBIO, INC. (IBIO) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets of $1.08 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Leases
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets · last filed 2021-05-17
- 2021-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $1.08M.
- 2020-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $964.00K.
- 2020-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $850.00K.
- 2020-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $753.00K.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets |
|---|---|
| 2021-03-31 | $1.08M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $964.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $850.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $753.00K 10-Q · filed 2021-05-17 |
| 2020-03-31 | $677.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $612.00K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $551.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $486.00K 10-K · filed 2020-10-13 |
| 2019-03-31 | $422.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $357.00K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $298.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $245.00K 10-K · filed 2019-08-26 |
| 2018-03-31 | $202.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $167.00K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $131.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $99.00K 10-K · filed 2018-09-18 |
| 2017-03-31 | $66.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $61.00K 10-Q · filed 2017-02-21 |
| 2016-09-30 | $46.00K 10-Q · filed 2016-11-18 |
| 2016-06-30 | $34.00K 10-K · filed 2017-09-15 |
| 2016-03-31 | $31.00K 10-Q · filed 2016-05-23 |
| 2015-06-30 | $27.00K 10-K · filed 2016-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |